Stage FocusSeed, Series A
GeographyUS
TypeVC
Last Activity2025
Industry Focus
Industries
BiotechMedtechAISynthetic Biology
Technical BenchStrong
Investor TypeDeepTech Specialist
ExposureMostly DeepTech Investments
Bio
Northpond Ventures is a life sciences and technology-focused VC with 74 portfolio companies, 5 IPOs, and 12 acquisitions including 908 Devices, Syapse, and Sherlock Biosciences. The fund has maintained consistent deployment with 6 investments in 2024 and 4 in early 2025, showing sustained activity in a market where many life sciences investors pulled back.
The synthetic biology angle is particula...
Notable Investments
9
908 DevicesS
SyapseS
SherlockSimilar Funds
Civilization Ventures
San Francisco, United States
DeepTech NativeBiotechSynthetic BiologyAISeedSeries A
Magnetic Ventures
United States
DeepTech NativeBiotechAIMedtechSeedSeries A
Ahren Innovation Capital
London, United Kingdom
DeepTech NativeBiotechRoboticsClimate TechSeedSeries A
ARCH Venture Partners
Chicago, United States
Pure DeepTechBiotechMedtechSynthetic BiologySeedSeries A
ARTIS Ventures
San Francisco, United States
DeepTech NativeBiotechAIMedtechSeedSeries A
Foresite Capital
San Francisco, United States
DeepTech NativeBiotechMedtechAISeedSeries A